T therapy targeting p95HER2 shows complete and durable tumor responses in HER2+ breast cancer preclinical models. Combining ...

In a recent study published in Nature, a team of scientists from Stanford University investigated the potential of chimeric ...

Immune-cell therapy shrank children's brain tumors, restored neurologic function and—for one participant—erased all ...

Engineered receptors could lead to more precisely targeted, effective cancer therapies with fewer side effects than existing ...

▎药明康德内容团队编辑  12年前，一名不到7岁的小女孩急性淋巴细胞白血病复发，危在旦夕。幸运的是，她接受了一项史无前例的治疗——医生们从她的身体里分离出一部分T细胞，先在实验室里对其进行基因改造，让这些细胞有能力识别癌细胞；随后，改造后的T细胞经过 ...

Glioblastoma is the most common kind of malignant brain tumor in adults. So far, no treatment has been able to make this ...

Researchers have developed an innovative CAR T-cell therapy to combat glioblastoma, the most common malignant brain tumor in ...

Santhosh K. Sadashiv, MD, discusses the role of chimeric antigen receptor T-cell therapy in patients with multiple myeloma.

LOUISVILLE, Ky. -- A CD70-targeted CAR T-cell therapy for advanced kidney cancer continued to show durable activity in ...

One-third of HER2-positive (HER2+) tumors express the P95HER2 protein, which associates with an aggressive form of breast ...